JANX
Janux Therapeutics, Inc.
Company overview
- Market capitalization
- $1.01B
- Employees
- 108
- Latest publication
- 2026-09-29
About Janux Therapeutics, Inc.
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer. The company's clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. It also develops JANX011, a CD19-targeted adaptive immune response modulator that is in phase 1 clinical study developed for autoimmune diseases. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates; and Bristol Myers Squibb to develop and commercialize an undisclosed, novel tumor-activated therapeutic targeting a validated solid tumor antigen expressed across several human cancer types. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10,267,000USD | 3,733,000USD | 10,000,000USD | 0USD | 0USD | -8,512,000USD | 8,897,000USD | 1,252,000USD |
| Research Development | 30,994,000USD | 26,813,000USD | 34,629,000USD | 34,664,000USD | 25,055,000USD | 20,806,000USD | 14,898,000USD | 14,070,000USD |
| General And Administrative Expenses | 10,963,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 41,957,000USD | 37,477,000USD | 44,750,000USD | 15,943,000USD | 9,842,000USD | 8,216,000USD | 22,213,000USD | 20,881,000USD |
| Operating Income | -31,690,000USD | -34,213,000USD | -35,251,000USD | -45,118,000USD | -34,897,000USD | -29,022,000USD | -13,822,000USD | -20,161,000USD |
| Total Other Income Expense Net | 9,718,000USD | 9,852,000USD | 10,938,000USD | 11,260,000USD | 11,389,000USD | 8,806,000USD | 7,863,000USD | 5,401,000USD |
| Net Income | -21,972,000USD | -24,361,000USD | -24,313,000USD | -33,858,000USD | -23,508,000USD | -20,216,000USD | -5,959,000USD | -14,760,000USD |
| Cost Of Revenue | — | 469,000USD | 501,000USD | 29,175,000USD | 25,055,000USD | 20,806,000USD | 506,000USD | 532,000USD |
| Gross Profit | — | 3,264,000USD | 9,499,000USD | -29,175,000USD | -25,055,000USD | -20,806,000USD | 8,391,000USD | 720,000USD |
| Selling General Administrative | — | 11,133,000USD | 10,622,000USD | 10,454,000USD | 9,842,000USD | 8,215,999USD | 7,821,000USD | 7,343,000USD |
| Interest Income | — | 9,852,000USD | 10,938,000USD | 11,260,000USD | 11,389,000USD | 8,806,000USD | 7,863,000USD | 5,401,000USD |
| Net Interest Income | — | 9,852,000USD | 10,938,000USD | 11,260,000USD | 11,389,000USD | 8,806,000USD | 7,863,000USD | 5,401,000USD |
| Income Before Tax | — | -24,361,000USD | -24,313,000USD | -33,858,000USD | -23,508,000USD | -20,216,000USD | -5,959,000USD | -14,760,000USD |
| Net Income From Continuing Ops | — | -24,361,000USD | -24,313,000USD | -33,858,000USD | -23,508,000USD | -20,216,000USD | -5,959,000USD | -14,760,000USD |
| Ebit | — | -24,361,000USD | -24,313,000USD | -33,858,000USD | -23,508,000USD | -20,216,000USD | -5,959,000USD | -14,760,000USD |
| Ebitda | — | -23,892,000USD | -23,812,000USD | -33,317,000USD | -22,989,000USD | -19,704,000USD | -5,453,000USD | -14,228,000USD |
| Depreciation And Amortization | — | 469,000USD | 501,000USD | 541,000USD | 519,000USD | 512,000USD | 506,000USD | 532,000USD |
| Reconciled Depreciation | — | 469,000USD | 501,000USD | 541,000USD | 519,000USD | 512,000USD | 506,000USD | 532,000USD |
| Unclassified Operating Expenses | — | — | — | -29,175,000USD | -25,055,000USD | -20,805,999USD | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | 488,724USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|
| Total Revenue | 8,612,000USD | 3,637,000USD | 0USD |
| Cost Of Revenue | 75,703,000USD | 36,566,000USD | 6,000USD |
| Gross Profit | 8,612,000USD | 3,637,000USD | -6,000USD |
| Research Development | 53,441,000USD | 26,237,000USD | 2,999,000USD |
| Selling General Administrative | 22,262,000USD | 10,329,000USD | 772,000USD |
| Total Operating Expenses | 75,703,000USD | 36,566,000USD | 3,771,000USD |
| Operating Income | -67,091,000USD | -32,929,000USD | -3,771,000USD |
| Interest Income | 4,032,000USD | 257,000USD | — |
| Interest Expense | 4,032,000USD | 370,000USD | 233,000USD |
| Net Interest Income | 4,032,000USD | 257,000USD | -233,000USD |
| Income Before Tax | -63,059,000USD | -32,672,000USD | -4,004,000USD |
| Income Tax Expense | -8,905,000USD | -113,000USD | 233,000USD |
| Net Income | -54,154,000USD | -32,559,000USD | -4,237,000USD |
| Net Income From Continuing Ops | -63,059,000USD | -32,672,000USD | -4,004,000USD |
| Ebit | -67,091,000USD | -32,929,000USD | -3,771,000USD |
| Ebitda | -66,250,000USD | -32,816,000USD | -3,765,000USD |
| Depreciation And Amortization | 841,000USD | 113,000USD | 6,000USD |
| Reconciled Depreciation | 841,000USD | 113,000USD | 6,000USD |
| Total Other Income Expense Net | 4,032,000USD | 257,000USD | -233,000USD |
| Non Operating Income Net Other | 4,032,000USD | 257,000USD | — |
| Net Income Applicable To Common Shares | -63,059,000USD | -32,672,000USD | -4,004,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,007,653,000USD | 1,028,225,000USD | 1,007,522,000USD | 1,024,766,000USD | 1,032,212,000USD | 1,050,772,000USD | 1,061,516,000USD | 695,019,000USD |
| Cash And Equivalents | 27,768,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 970,913,000USD | 956,386,000USD | 966,567,000USD | 988,993,000USD | 996,011,000USD | 1,014,146,000USD | 1,025,173,000USD | 658,031,000USD |
| Short Term Investments | 943,145,000USD | 904,558,000USD | 914,233,000USD | 940,604,000USD | 943,565,000USD | 940,403,000USD | 594,568,000USD | 631,277,000USD |
| Total Current Assets | 983,337,000USD | 1,002,049,000USD | 975,887,000USD | 998,086,000USD | 1,005,553,000USD | 1,023,339,000USD | 1,033,666,000USD | 666,321,000USD |
| Other Current Assets | 12,275,000USD | 3,200,000USD | 2,892,000USD | 2,778,000USD | 3,851,000USD | 3,608,000USD | 3,112,000USD | 3,836,000USD |
| Other Non Current Assets | 2,913,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 79,669,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 60,152,000USD | 58,915,000USD | 24,997,000USD | 27,831,000USD | 21,379,000USD | 17,502,000USD | 17,459,000USD | 17,173,000USD |
| Other Current Liabilities | 19,513,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 927,984,000USD | 941,535,000USD | 956,822,000USD | 976,555,000USD | 990,516,000USD | 1,012,469,000USD | 1,022,781,000USD | 656,104,000USD |
| Total Equity Including Noncontrolling Interest | 927,984,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 35,070,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 1,079,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 20,587,000USD | 21,416,000USD | 22,254,000USD | 23,237,000USD | 23,150,000USD | 23,825,000USD | 24,150,000USD | 25,059,000USD |
| Accounts Payable | 3,017,000USD | 3,376,000USD | 4,971,000USD | 3,395,000USD | 3,477,000USD | 2,351,000USD | 4,026,000USD | 2,462,000USD |
| Short Term Debt | 2,552,000USD | 2,472,000USD | 2,393,000USD | 2,280,000USD | 1,873,000USD | 1,811,000USD | 1,749,000USD | 1,689,000USD |
| Common Stock | 61,000USD | 60,000USD | 60,000USD | 60,000USD | 59,000USD | 59,000USD | 59,000USD | 52,000USD |
| Retained Earnings | -397,715,000USD | -375,743,000USD | -351,382,000USD | -319,436,000USD | -295,123,000USD | -261,265,000USD | -237,757,000USD | -217,541,000USD |
| Accumulated Other Comprehensive Income | -2,305,000USD | 576,000USD | 4,316,000USD | 4,562,000USD | 3,747,000USD | 3,756,000USD | 2,163,000USD | 7,831,000USD |
| Total Liab | — | 86,690,000USD | 50,700,000USD | 48,211,000USD | 41,696,000USD | 38,303,000USD | 38,735,000USD | 38,915,000USD |
| Other Current Liab | — | 15,476,000USD | 17,633,000USD | 22,156,000USD | 16,029,000USD | 13,340,000USD | 11,684,000USD | 13,022,000USD |
| Capital Stock | — | 60,000USD | 60,000USD | 60,000USD | 59,000USD | 59,000USD | 59,000USD | 52,000USD |
| Cash | — | 51,828,000USD | 52,334,000USD | 48,389,000USD | 52,446,000USD | 73,743,000USD | 430,605,000USD | 26,754,000USD |
| Current Deferred Revenue | — | 37,591,000USD | — | — | — | — | — | — |
| Net Debt | — | -30,257,000USD | -30,195,000USD | -25,729,000USD | -30,256,000USD | -51,131,000USD | -407,580,000USD | -3,323,000USD |
| Short Long Term Debt Total | — | 21,571,000USD | 22,139,000USD | 22,660,000USD | 22,190,000USD | 22,612,000USD | 23,025,000USD | 23,431,000USD |
| Net Receivables | — | 42,463,000USD | 6,428,000USD | 6,315,000USD | 5,691,000USD | 5,585,000USD | 5,381,000USD | 4,454,000USD |
| Property Plant Equipment Gross | — | 28,768,000USD | 29,221,000USD | 29,736,000USD | 29,162,000USD | 29,296,000USD | 29,102,000USD | 29,502,000USD |
| Common Stock Shares Outstanding | — | 62,665,717shares | 61,966,999shares | 62,023,685shares | 61,902,411shares | 61,791,721shares | 56,832,374shares | 54,628,670shares |
| Non Current Assets Total | — | 26,176,000USD | 31,635,000USD | 26,680,000USD | 26,659,000USD | 27,433,000USD | 27,850,000USD | 28,698,000USD |
| Non Current Liabilities Total | — | 27,775,000USD | 25,703,000USD | 20,380,000USD | 20,317,000USD | 20,801,000USD | 21,276,000USD | 21,742,000USD |
| Non Currrent Assets Other | — | 4,760,000USD | 2,608,000USD | 2,627,000USD | 2,693,000USD | 3,608,000USD | 3,700,000USD | 3,639,000USD |
| Net Working Capital | — | 943,134,000USD | 950,890,000USD | 970,255,000USD | 984,174,000USD | 1,005,837,000USD | 1,016,207,000USD | 649,148,000USD |
| Unclassified Non Current Liabilities | — | 27,775,000USD | 25,703,000USD | 20,380,000USD | 20,317,000USD | 20,801,000USD | 21,276,000USD | 21,742,000USD |
| Unclassified Equity | — | 1,316,582,000USD | 1,303,768,000USD | 1,291,309,000USD | 1,281,774,000USD | 1,269,860,000USD | 1,258,257,000USD | 865,710,000USD |
| Unclassified Non Current Assets | — | — | 6,773,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 1,007,522,000USD | 1,061,516,000USD | 380,407,000USD | 364,010,000USD | 379,824,000USD | 16,217,000USD | 679,000USD |
| Other Current Assets | 2,892,000USD | 3,112,000USD | 5,213,000USD | 5,423,000USD | 1,854,000USD | 249,000USD | — |
| Total Liab | 50,700,000USD | 38,735,000USD | 36,058,000USD | 43,270,000USD | 13,497,000USD | 30,855,000USD | 8,623,000USD |
| Total Stockholder Equity | 956,822,000USD | 1,022,781,000USD | 344,349,000USD | 320,740,000USD | 366,327,000USD | -14,638,000USD | -7,944,000USD |
| Other Current Liab | 17,633,000USD | 11,684,000USD | 7,387,000USD | 8,179,000USD | 4,982,000USD | 803,000USD | 360,000USD |
| Common Stock | 60,000USD | 59,000USD | 46,000USD | 42,000USD | 41,000USD | 1,000USD | 1,000USD |
| Capital Stock | 60,000USD | 59,000USD | 46,000USD | 42,000USD | 41,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -351,382,000USD | -237,757,000USD | -168,763,000USD | -110,470,000USD | -47,411,000USD | -14,739,000USD | -7,955,000USD |
| Cash | 52,334,000USD | 430,605,000USD | 19,205,000USD | 51,426,000USD | 35,582,000USD | 7,813,000USD | 658,000USD |
| Cash And Short Term Investments | 966,567,000USD | 1,025,173,000USD | 344,028,000USD | 327,016,000USD | 374,965,000USD | 7,813,000USD | 658,000USD |
| Total Current Assets | 975,887,000USD | 1,033,666,000USD | 349,241,000USD | 332,439,000USD | 377,019,000USD | 16,062,000USD | 658,000USD |
| Total Current Liabilities | 24,997,000USD | 17,459,000USD | 13,033,000USD | 16,507,000USD | 12,797,000USD | 3,181,000USD | 4,627,000USD |
| Net Debt | -30,195,000USD | -407,580,000USD | 5,337,000USD | -26,121,000USD | -35,388,000USD | -7,813,000USD | 3,342,000USD |
| Short Term Debt | 2,393,000USD | 1,749,000USD | 1,517,000USD | 763,000USD | 194,000USD | 751,000USD | 4,000,000USD |
| Short Long Term Debt Total | 22,139,000USD | 23,025,000USD | 24,542,000USD | 25,305,000USD | 194,000USD | — | 4,000,000USD |
| Short Term Investments | 914,233,000USD | 594,568,000USD | 324,823,000USD | 275,590,000USD | 339,383,000USD | 0USD | — |
| Net Receivables | 6,428,000USD | 5,381,000USD | 2,200,000USD | 700,000USD | 200,000USD | 8,000,000USD | 0USD |
| Accounts Payable | 4,971,000USD | 4,026,000USD | 2,424,000USD | 2,159,000USD | 2,458,000USD | 428,000USD | 267,000USD |
| Property Plant Equipment Net | 22,254,000USD | 24,150,000USD | 27,841,000USD | 29,365,000USD | 1,597,000USD | 155,000USD | 21,000USD |
| Property Plant Equipment Gross | 29,221,000USD | 29,102,000USD | 30,755,000USD | 29,365,000USD | 1,597,000USD | 155,000USD | 21,000USD |
| Accumulated Other Comprehensive Income | 4,316,000USD | 2,163,000USD | 665,000USD | -1,535,000USD | -270,000USD | -21,624,000USD | -3,996,000USD |
| Common Stock Shares Outstanding | 61,966,999shares | 53,751,480shares | 44,016,283shares | 41,469,631shares | 41,243,137shares | 41,611,510shares | 41,611,510shares |
| Non Current Assets Total | 31,635,000USD | 27,850,000USD | 31,166,000USD | 31,571,000USD | 2,805,000USD | 155,000USD | 21,000USD |
| Non Current Liabilities Total | 25,703,000USD | 21,276,000USD | 23,025,000USD | 26,763,000USD | 700,000USD | 27,674,000USD | 3,996,000USD |
| Non Currrent Assets Other | 2,608,000USD | 3,700,000USD | 3,325,000USD | 1,390,000USD | 1,208,000USD | -155,000USD | -21,000USD |
| Net Working Capital | 950,890,000USD | 1,016,207,000USD | 336,208,000USD | 315,932,000USD | 364,222,000USD | 12,881,000USD | -3,969,000USD |
| Unclassified Non Current Assets | 6,773,000USD | — | — | -1,390,000USD | -1,208,000USD | — | — |
| Unclassified Non Current Liabilities | 25,703,000USD | 21,276,000USD | 23,025,000USD | -2,221,000USD | — | 21,624,000USD | 3,996,000USD |
| Unclassified Equity | 1,303,768,000USD | 1,258,257,000USD | 512,355,000USD | 432,661,000USD | 413,926,000USD | 21,723,000USD | 4,005,000USD |
| Current Deferred Revenue | — | — | 1,705,000USD | 5,406,000USD | 5,163,000USD | 1,950,000USD | — |
| Inventory | — | — | -2,200,000USD | -700,000USD | -200,000USD | — | — |
| Other Liab | — | — | — | 2,221,000USD | 700,000USD | 6,050,000USD | — |
| Other Assets | — | — | — | 2,206,000USD | 1,208,000USD | — | — |
| Non Current Liabilities Other | — | — | — | 26,763,000USD | 700,000USD | — | — |
| Net Tangible Assets | — | — | — | 320,740,000USD | 366,327,000USD | -14,638,000USD | -7,944,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 4,000,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -4,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -24,361,000USD | -31,946,000USD | -24,313,000USD | -33,858,000USD | -23,508,000USD | -20,216,000USD | -28,059,000USD | -5,959,000USD |
| Depreciation | 469,000USD | 468,000USD | 501,000USD | 541,000USD | 519,000USD | 512,000USD | 510,000USD | 506,000USD |
| Stock Based Compensation | 9,269,000USD | 9,515,000USD | 9,044,000USD | 10,960,000USD | 10,702,000USD | 6,251,000USD | 15,387,000USD | 5,757,000USD |
| Other Non Cash Items | -2,624,000USD | -3,524,000USD | -4,623,000USD | -5,206,000USD | -4,221,000USD | -2,927,000USD | -2,898,000USD | -2,973,000USD |
| Change To Account Receivables | -35,000,000USD | — | — | 0USD | 0USD | — | 7,500,000USD | -6,981,000USD |
| Change In Working Capital | 4,910,000USD | -3,055,000USD | 6,535,000USD | 3,750,000USD | -516,000USD | -345,000USD | 12,829,000USD | -7,352,000USD |
| Total Cash From Operating Activities | -12,337,000USD | -28,542,000USD | -12,856,000USD | -23,813,000USD | -17,024,000USD | -16,725,000USD | -2,231,000USD | -10,021,000USD |
| Capital Expenditures | -273,000USD | -106,000USD | -93,000USD | -473,000USD | -371,000USD | -42,000USD | -25,000USD | -95,000USD |
| Free Cash Flow | -12,610,000USD | -28,648,000USD | -12,949,000USD | -24,286,000USD | -17,395,000USD | -16,767,000USD | -2,256,000USD | -10,116,000USD |
| Investments | 8,559,000USD | 29,649,000USD | 8,306,000USD | 1,562,000USD | -340,392,000USD | 33,926,000USD | 12,674,000USD | -190,885,000USD |
| Total Cashflows From Investing Activities | 8,286,000USD | 29,543,000USD | 8,306,000USD | 1,562,000USD | -340,392,000USD | 33,926,000USD | 12,674,000USD | -190,885,000USD |
| Total Cash From Financing Activities | 3,545,000USD | 2,944,000USD | 493,000USD | 954,000USD | 554,000USD | 386,650,000USD | 1,649,000USD | 2,765,000USD |
| Sale Purchase Of Stock | 0USD | 0USD | 0USD | 0USD | -347,000USD | — | — | — |
| Change In Cash | -506,000USD | 3,945,000USD | -4,057,000USD | -21,297,000USD | -356,862,000USD | 403,851,000USD | 12,092,000USD | -198,141,000USD |
| Begin Period Cash Flow | 52,334,000USD | 49,205,000USD | 53,262,000USD | 74,559,000USD | 431,421,000USD | 27,570,000USD | 14,662,000USD | 213,619,000USD |
| End Period Cash Flow | 51,828,000USD | 53,150,000USD | 49,205,000USD | 53,262,000USD | 74,559,000USD | 431,421,000USD | 26,754,000USD | 15,478,000USD |
| Unclassified Financing Cash Flow | 3,545,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -300,981,000USD | — | — | — | — | — | -190,790,000USD |
| Other Cashflows From Financing Activities | — | 2,944,000USD | 493,000USD | — | 901,000USD | 8,442,000USD | 1,649,000USD | 3,220,000USD |
| Unclassified Investing Cash Flow | — | 300,981,000USD | — | — | — | — | — | 190,885,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 378,208,000USD | 0USD | -455,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -113,625,000USD | -68,994,000USD | -58,293,000USD | -32,672,000USD | -6,784,000USD | -4,004,000USD |
| Depreciation | 2,029,000USD | 2,060,000USD | 1,955,000USD | 113,000USD | 13,000USD | 6,000USD |
| Stock Based Compensation | 40,221,000USD | 33,020,000USD | 20,005,000USD | 6,910,000USD | 72,000USD | 6,000USD |
| Other Non Cash Items | -17,574,000USD | -10,585,000USD | -7,688,000USD | -169,000USD | 1,941,000USD | 233,000USD |
| Change In Working Capital | 6,714,000USD | 685,000USD | -6,554,000USD | 8,842,000USD | 389,000USD | -69,000USD |
| Total Cash From Operating Activities | -82,235,000USD | -43,814,000USD | -50,575,000USD | -16,976,000USD | -4,369,000USD | -3,828,000USD |
| Capital Expenditures | -1,043,000USD | -359,000USD | -1,850,000USD | -1,482,000USD | -1,482,000USD | -1,482,000USD |
| Free Cash Flow | -83,278,000USD | -44,173,000USD | -52,425,000USD | -18,458,000USD | -4,369,000USD | -3,828,000USD |
| Investments | -299,938,000USD | -258,021,000USD | -53,921,000USD | -339,481,000USD | -339,481,000USD | -339,481,000USD |
| Total Cashflows From Investing Activities | -300,981,000USD | -258,021,000USD | -41,194,000USD | -340,963,000USD | -340,963,000USD | -340,963,000USD |
| Total Cash From Financing Activities | 4,945,000USD | 713,235,000USD | 59,548,000USD | 386,524,000USD | 11,524,000USD | 4,000,000USD |
| Sale Purchase Of Stock | -347,000USD | — | — | 204,167,000USD | — | — |
| Change In Cash | -378,271,000USD | 411,400,000USD | -32,221,000USD | 28,585,000USD | 7,155,000USD | 172,000USD |
| Begin Period Cash Flow | 431,421,000USD | 20,021,000USD | 52,242,000USD | 7,813,000USD | 658,000USD | 486,000USD |
| End Period Cash Flow | 53,150,000USD | 431,421,000USD | 20,021,000USD | 36,398,000USD | 7,813,000USD | 658,000USD |
| Other Cashflows From Investing Activities | -300,981,000USD | — | — | -339,481,000USD | — | — |
| Other Cashflows From Financing Activities | 4,945,000USD | 14,968,000USD | 3,018,000USD | 182,357,000USD | 9,024,000USD | 4,000,000USD |
| Unclassified Investing Cash Flow | 300,981,000USD | — | 14,577,000USD | 339,481,000USD | — | — |
| Issuance Of Capital Stock | — | 698,267,000USD | 56,530,000USD | 384,714,000USD | 8,954,000USD | 0USD |
| Change To Account Receivables | — | — | 500,000USD | 8,000,000USD | -8,000,000USD | -8,000,000USD |
| Change To Inventory | — | — | — | 831,000USD | 375,000USD | — |
| Change To Liabilities | — | — | — | 2,000USD | 8,014,000USD | 4,000USD |
| Net Borrowings | — | — | — | 180,547,000USD | 2,500,000USD | 4,000,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 28,585,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | -180,547,000USD | -8,954,000USD | -4,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.